Scienture Holdings (SCNX)
NASDAQ:SCNX
SCNX Stock Chart & Stats
$0.55
-$0.13(-2.47%)
At close: 4:00 PM EST
$0.55
-$0.13(-2.47%)
Day’s Range― - ―
52-Week Range$0.24 - $2.60
Previous CloseN/A
Volume1.53K
Average Volume (3M)4.08M
Market Cap
$12.04M
Enterprise Value-$6.63B
Total Cash (Recent Filing)$6.66B
Total Debt (Recent Filing)$24.14M
Price to Earnings (P/E)―
Beta3.32
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding40,630,814
10 Day Avg. Volume11,411,402
30 Day Avg. Volume4,082,790
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)<0.01
Price to Sales (P/S)181.35
P/FCF Ratio>-0.01
Enterprise Value/Market Cap-550.99
Enterprise Value/Revenue-15.37K
Enterprise Value/Gross Profit-20.01
Enterprise Value/Ebitda170.38
Forecast
1Y Price Target
$1.50Price Target Upside172.73% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improved Leverage ProfileRecent lower leverage reduces near-term refinancing and liquidity stress, preserving financial flexibility. That better capital structure gives management more time to stabilize operations or pursue restructuring, lowering bankruptcy risk over the next several months.
High Gross Margin SpikeA very high TTM gross margin implies the core offering can deliver strong unit economics. If revenue stabilizes, high gross margins provide structural capacity to restore operating profitability as fixed costs are absorbed, supporting durable margin recovery.
Lean, Capital-light StaffingA headcount of 14 indicates a very lean operating model consistent with software/information services. Low fixed payroll expense improves operating leverage potential and reduces cash burn sensitivity, aiding scalability when revenue growth resumes.
Bears Say
Persistent Negative Cash FlowSustained deeply negative OCF and FCF creates ongoing cash burn that forces reliance on external financing. This structural cash weakness limits reinvestment, increases dilution or debt risk, and constrains strategic flexibility over months ahead.
Volatile, Loss-making OperationsChronic negative operating and net margins signal the business currently fails to convert revenue to sustainable profits. Without durable margin improvement, retained losses will persist, undermining balance sheet strength and impairing long-term viability.
Severe Revenue DeclineA ~73% decline in trailing revenue and sharp drops in 2023–2024 indicate structurally weak demand or execution failures. Persistent revenue erosion reduces scale benefits, lengthens payback on costs, and raises probability of further financing needs.
Scienture Holdings News
SCNX FAQ
What was Scienture Holdings’s price range in the past 12 months?
Scienture Holdings lowest stock price was $0.24 and its highest was $2.60 in the past 12 months.
What is Scienture Holdings’s market cap?
Scienture Holdings’s market cap is $12.04M.
When is Scienture Holdings’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Scienture Holdings’s earnings last quarter?
Currently, no data Available
Is Scienture Holdings overvalued?
According to Wall Street analysts Scienture Holdings’s price is currently Undervalued.
Does Scienture Holdings pay dividends?
Scienture Holdings pays a Notavailable dividend of $1.5 which represents an annual dividend yield of N/A. See more information on Scienture Holdings dividends here
What is Scienture Holdings’s EPS estimate?
Scienture Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Scienture Holdings have?
Scienture Holdings has 40,630,814 shares outstanding.
What happened to Scienture Holdings’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Scienture Holdings?
Currently, no hedge funds are holding shares in SCNX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Scienture Holdings
TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.
SCNX Stock 12 Month Forecast
Average Price Target
$1.50
▲(172.73% Upside)
Technical Analysis
Ownership Overview
16.82% Insiders
1.08% Mutual Funds
0.13% Other Institutional Investors
80.97% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---